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ABSTRACT:   29 
Low birth-weight and rapid postnatal-growth increases the risk of developing insulin 30 
resistance and type-2 diabetes in later life. However underlying mechanisms and potential 31 
intervention strategies are poorly defined. Here we demonstrate that male Wistar rats exposed 32 
to a low-protein diet in-utero that had a low birth weight but then underwent postnatal catch-33 
up growth (recuperated offspring) had reductions in the insulin signaling proteins p110-β [13 34 
± 6% of controls] (p<0.001) and IRS-1 [39 ± 10% of controls] (p<0.05) in adipose tissue. 35 
These changes were not accompanied by any change in expression of the corresponding 36 
mRNAs, suggesting post-transcriptional regulation. Recuperated animals displayed evidence 37 
of a pro-inflammatory phenotype of their adipose tissue with increased interleukin-6 (IL-6) 38 
[139 ± 8%], (p<0.05) and interleukin-1β (IL1-β) [154 ± 16%], (p<0.05) that may contribute to 39 
the insulin signaling protein dysregulation. Post-weaning dietary supplementation of 40 
recuperated animals with Coenzyme Q (CoQ10) (1mg/kg of body weight/day) prevented the 41 
programmed reduction in IRS-1 and p110-β and the programmed increased in IL-6. These 42 
findings suggest that post-weaning CoQ10 supplementation has anti-inflammatory properties 43 
and can prevent programmed changes in insulin-signaling protein expression. We conclude 44 
that CoQ10 supplementation represents an attractive intervention strategy to prevent the 45 
development of insulin resistance that results from suboptimal in-utero nutrition. 46 
47 
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 INTRODUCTION: 48 
Many epidemiological studies have demonstrated that a suboptimal fetal 49 
environment, resulting in low birth weight (LBW) can result in increased risk of glucose 50 
intolerance, (1, 2) insulin resistance (3) and type 2 diabetes (T2D) (4, 5) in later life. Animal 51 
models of intrauterine growth restriction (IUGR) have very similar phenotypes to LBW 52 
humans. Using a well-established model of maternal protein restriction that generates LBW 53 
offspring, we have demonstrated that the growth-restricted pups develop an insulin resistant 54 
and diabetic phenotype in later life (6). These offspring show alterations in key insulin 55 
signaling molecules in skeletal muscle and adipose tissue that are markedly similar to those 56 
observed in men with LBW (7-9).  The risk for development of poor glucose tolerance (10), 57 
insulin resistance (11, 12) and T2D (13, 14) is exacerbated when LBW is combined with 58 
rapid postnatal growth. We have recently demonstrated that dysregulation of insulin signaling 59 
protein expression in adipose tissue occurs prior to the development of whole-body insulin 60 
resistance and is a very early consequence of LBW and catch-up growth (15). 61 
Oxidative stress plays an important role in the etiology of insulin resistance (16) and 62 
in adipose tissue this is associated with increased inflammation (17).  Oxidative stress 63 
accumulation is a common underlying consequence of many sub-optimal in-utero 64 
environments (18). Consequently, several studies have utilized antioxidant therapy during 65 
pregnancy in order to attempt to prevent the observed deleterious phenotypes resulting from a 66 
suboptimal in-utero environment (19 - 21). These demonstrate proof of principle that 67 
antioxidants can prevent detrimental effects of developmental programming; however, the 68 
doses employed in these studies far exceed those suitable for use in pregnant women. 69 
Furthermore, it is also important to address the potential beneficial effects of targeted 70 
postnatal antioxidant supplementation as, often evidence is not present for suboptimal in utero 71 
exposure until at the time of, or just after, delivery and supplementation could be detrimental 72 
to those that don’t need it  73 
Previously, we demonstrated that postnatal supplementation of coenzyme Q, also 74 
known as ubiquinone, (CoQ) at a clinically relevant dose can prevent a programmed 75 
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accelerated aging phenotype in the aorta (22) and heart (23) of rats that were born small and 76 
underwent catch-up growth. CoQ exists in various isoforms which differ in concentration 77 
between organisms. In humans, the most abundant form of CoQ is CoQ10 (as it contains 10 78 
isoprenoid units attached to a benzoquinone ring); in rodents, however, CoQ9 (containing 9 79 
isoprenoid units) is the most abundant form. It is also known that rodents can convert dietary 80 
CoQ10 into CoQ9 (23). CoQ is the most abundant and potent antioxidant in the body (24) with 81 
additional anti-inflammatory properties, including decreasing the production of pro-82 
inflammatory cytokines (25). Clinical trials have confirmed the safety of CoQ up to doses of 83 
1200 mg/kg/day (26, 27). 84 
This study therefore aimed to establish whether a postnatal dietary supplementation 85 
of CoQ could alter any observed dysregulation of insulin signaling in rats exposed to a 86 
suboptimal environment in-utero and postnatal catch-up growth and then to investigate the 87 
potential underlying mechanisms, including oxidative stress status and inflammatory 88 
phenotypes.  89 
90 
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MATERIALS AND METHODS: 91 
Animal Experimentation 92 
All procedures involving animals were conducted under the British Animals 93 
(Scientific Procedures) Act (1986).  Pregnant Wistar rats were maintained on a 20% protein 94 
diet (control) or an isocaloric low-protein (LP) (8%) diet fed ad libitum, as previously 95 
described (28). Both diets were purchased from Arie Blok, The Netherlands.  The day of birth 96 
was recorded as day 1 of postnatal life. Pups born to LP diet-fed dams were cross-fostered to 97 
control-fed mothers on postnatal day 3 in order to create a recuperated litter. Each recuperated 98 
litter was culled to 4 male pups at random to maximize their plane of nutrition. The control 99 
group constituted offspring of mothers fed the 20% protein diet and suckled by 20% protein 100 
fed dams. Each control litter was culled to 8 pups as a standard. To prevent any stress to the 101 
animals during cross-fostering, pups were transferred with their own bedding.. At 21 days, 102 
two males per litter were weaned onto standard laboratory chow (Special Diet Services) and 103 
the other two were weaned onto the same diet supplemented with CoQ to give a dose of 1 104 
mg/kg body weight/day. Animals were maintained on these diets until 3 months of age. Body 105 
weights were recorded at postnatal days 3, 7, 14, 21 and 3 months of age. All animals were 106 
killed by CO2 asphyxiation. At post mortem, epididymal fat pads, liver and vastus lateralis 107 
skeletal muscle were removed, weighed, and snap frozen in liquid nitrogen and then stored at 108 
-80 ºC until analysis. For all measurements, one pup per litter was used, thus N indicated 109 
throughout represents number of litters. Only male animals were used in this study. 110 
 111 
CoQ  diet preparation 112 
A dose of 1 mg CoQ /kg of body weight per day was used in this study. This was 113 
achieved by appropriate CoQ supplementation of laboratory chow as described previously 114 
(22, 23). Briefly, CoQ was impregnated into the diet pellets by dissolving CoQ10 in acetone 115 
and mixing this with the diet pellets. The mix was then left in a fume hood overnight to allow 116 
evaporation of acetone. The diet was prepared twice a week throughout the study.  117 
 118 
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CoQ, lipid profile, glucose and insulin analysis 119 
Serum was obtained from blood collected from the tail vein after overnight fasting. 120 
The blood clotted for 30 minutes before centrifugation for 3 minutes at 845 g. Fasted blood 121 
glucose measurements were obtained using a blood glucose analyser (Hemocue). The lipid 122 
profile and fasted serum insulin analysis was performed using an auto analyzer (Clinical 123 
Chemistry Laboratory, Medical Research Council Centre for Obesity and Related Metabolic 124 
Diseases, Cambridge, UK). Blood from the tail vein was collected into heparin tubes and 125 
centrifuged to isolate plasma. Plasma CoQ10 levels were determined by reverse-phased HPLC 126 
with UV detection at 275 nm as previously described (22).   127 
 128 
Protein analysis 129 
Protein was extracted and assayed as described previously (29) and 20 g protein was 130 
loaded onto 10-15% polyacrylamide gels, dependent upon the molecular weight of the target 131 
protein. The samples were then electrophoresed and transferred to polyvinylidene fluoride 132 
membranes (22) and antibodies to the following proteins were detected: IL-6, IL1β (Abcam), 133 
IRS-1, p110-β, p85α (Merck Millipore), Akt-1, (Cell Signaling Technology), and Akt-2, pAkt 134 
(ser473) (New England Biolabs). (Please see the Antibody table for further details). Anti-rabbit 135 
and anti-mouse IgG horseradish peroxidase-linked secondary antibodies were from Jackson 136 
Immunoresearch Laboratories. Equal protein loading was confirmed by staining 137 
electrophoresed gels with Coomassie Blue (Bio-Rad, Hemel Hempstead, Hertfordshire, UK) 138 
to visualize total protein.  To ensure the chemiluminescent signal changed in a linear manner, 139 
the ratio between loading controls (50% and 100% pooled sample) was confirmed for each 140 
detected protein. Protein bands were detected using West Pico Chemiluminescence reagent 141 
(Pierce, Thermo Scientific) and analyzed using Alphaease Imaging Software (Alpha 142 
Innotech).  143 
 144 
Gene expression 145 
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 RNA was extracted using a miRNeasy mini kit (Qiagen) following the manufacturers 146 
instructions (22), a DNAse digestion step was performed in order to ensure no gDNA 147 
contamination. RNA (1 ug) was used to synthesize cDNA using oligo-dT primers and M-MLV 148 
reverse transcriptase (Promega, Southampton, Hants, UK). Gene expression was determined 149 
using custom designed primers (Sigma) and SYBR Green reagents (Applied Biosystems). 150 
(Primer sequences are described in Table 1). 151 
 Quantification of gene expression (expressed as average copy number) was 152 
performed using the Step One Plus q-PCR machine (Applied Biosystems). Melting curve 153 
analysis was performed to confirm absence of primer-dimers. Equal efficiency of the reverse 154 
transcription of RNA from all groups was confirmed through quantification of expression of the 155 
housekeeping gene β-actin. Expression did not differ between groups (effect of maternal diet 156 
p=0.72; (control; 153 ± 32, recuperated; 134 ± 35 average copy number).  157 
 158 
microRNA (miRNA) analysis 159 
 Putative miRNAs targeting the 3' untranslated regions (3'UTRs) of p110β and IRS-1 160 
were identified using the miRanda/mirSVR 1.2 (Release 2010) and miRmap 3 (Release 1.1) 161 
prediction algorithms, respectively. Candidates were ranked according to the strength of the 162 
predicted interaction, high conservation across species and target site position along the 163 
mRNA (higher scores for proximal and distal locations). The final selection of the most 164 
highly ranked candidates to assess was based on common target sites within both the p110β 165 
and IRS-1 3'UTRs as well as information regarding their expression in white adipose tissue. 166 
RNA was extracted using a Direct-zolTM RNA MiniPrep kit (Zymo Research), in order to 167 
retain RNA species with a minimal length of 17 nucleotides. RNA purity and concentration 168 
was determined by spectrophotometric analysis on a NanoDrop ND-1000. RNA integrity was 169 
confirmed by denaturing agarose gel electrophoresis.  170 
  171 
Statistical Analysis 172 
8 
Data were analyzed using a 2-way ANOVA with maternal diet and CoQ 173 
supplementation as the independent variables. Data are represented as mean ± S.E.M.  A 174 
value of p<0.05 was considered statistically significant. All statistical analyses were 175 
performed using Statistica 7 software (Statsoft Inc) except for miRNA analysis where 176 
GraphPad Prism 6.0 (GraphPad) was utilised. In all cases, N refers to the number of litters.177 
9 
RESULTS: 178 
Physical parameters, plasma CoQ, lipid profile and insulin data 179 
Recuperated offspring were born smaller [(6.3 ± 0.2g vs. 7.4 ± 0.2g); (p<0.001)] than 180 
control animals and remained smaller at postnatal day 7 [(13.4g ± 0.4 vs. 16.4g ± 0.4); 181 
(p<0.001)]. By postnatal days 14 (33.7 ± 0.5g vs. 33.3 ± 0.8g) and 21 (52.2 ± 3.7 vs. 50.8 ± 182 
1.2g), the recuperated offspring had undergone accelerated catch-up growth and were 183 
therefore of similar weight to the control offspring. At 3 months of age, there was no 184 
significant effect of CoQ supplementation and maternal diet on offspring body or liver 185 
weights (Table 2). However, maternal diet increased (p<0.05) epididymal fat pad weight 186 
(Table 2). There was no significant effect of CoQ supplementation on epididymal fat pad 187 
weight. Furthermore, no significant effect of maternal diet upon offspring plasma CoQ levels 188 
was observed. However, plasma CoQ levels were significantly (p<0.01) increased by CoQ 189 
supplementation (Figure 1). Serum levels of fasting insulin, triglycerides, free fatty acids, 190 
total cholesterol and fasting plasma glucose were unaltered by maternal diet or CoQ 191 
supplementation and there was no interaction between these two variables on any of the 192 
serum levels (Table 3). 193 
 194 
Insulin signaling: protein, mRNA and miRNA analysis 195 
a) Effect of maternal diet: Protein expression of IRS-1 (p<0.05) and p110-β 196 
(p<0.001) were reduced in the epididymal fat pads of recuperated offspring compared to 197 
controls (Figure 2A). In contrast, PKC-ζ protein levels were significantly (p<0.05) increased 198 
in the recuperated group (Figure 2A). Gene (mRNA) expression of these molecules were 199 
unaffected by maternal diet (Figure 3A). In liver and vastus lateralis skeletal muscle, IRS-1 200 
and p110-β protein expression remained unaltered by maternal diet. However, liver PKC-ζ 201 
protein levels displayed an increase (p<0.001) (Figures 2B and 2C). The mRNA levels of 202 
these three genes were not different in either the liver or muscle of recuperated offspring 203 
when compared to controls (Figures 3B and 3C). Protein expression of other insulin signaling 204 
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molecules including IRβ, p85α, Akt-1, Akt-2, pAkt(Ser473), and GLUT-4 were unaffected by 205 
maternal diet in the epididymal fat, liver and vastus lateralis muscle (Table 4).  206 
The programmed reduction in adipose tissue IRS-1 and p110-β in the absence of any 207 
differences in the corresponding mRNAs suggested that this effect was mediated by a post-208 
transcriptional mechanism. However, we saw no effects of maternal diet on the five miRNAs 209 
predicted to regulate p110-β (miR-25, miR-301a, miR-19a, miR-130a and miR-130b) or the 210 
two predicted to regulate IRS-1 (miR-126 and miR-143), (Figures 4A and B). 211 
b) Effect of CoQ supplementation: CoQ supplementation significantly increased both IRS-1 212 
and p110-β protein levels in recuperated offspring epididymal fat. In control offspring, CoQ 213 
supplementation had no effect on p110-β levels; however supplementation increased IRS-1 214 
protein expression (Figure 2A). CoQ supplementation increased (p<0.001) p110-β protein 215 
expression in both liver and VL skeletal muscle (Figures 2B and C). CoQ supplementation 216 
significantly (p<0.001) decreased PKC-ζ protein levels in recuperated adipose tissue 217 
compared to the effect on control offspring (Figure 2A); however, PKC-ζ expression 218 
remained similar in the liver and vastus lateralis muscle (Figures 2B and C). 219 
Cytokine analysis 220 
 Adipose tissue protein expression of IL-6 (p<0.05) and IL-1β (p<0.01) were increased 221 
in recuperated offspring (Figure 5A). CoQ supplementation significantly (p<0.05) reduced IL-222 
6 levels back to that of the controls, however, IL-1β levels were unchanged by CoQ 223 
supplementation (Figure 5 A). mRNA levels of Tgfb1 and Lep were unaltered by maternal 224 
diet; however, CoQ supplementation reduced Tgf-1 (p<0.001) and Lep (p<0.05) levels 225 
(Figure 5B). Tnf-α and Mcp-1 gene expression were similar between all groups (Figure 5B). 226 
There was no significant effect of maternal diet or CoQ10 supplementation on adiponectin 227 
(adipoq) mRNA in epididymal fat (control: 100 ± 26.6%; recuperated: 107 ± 18%; control 228 
CoQ: 91 ± 32%; recuperated CoQ: 73 ± 9%). 229 
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Reactive oxygen species (ROS) and antioxidant defense capacity 230 
4-HNE (4-hydroxynoneal; a marker of lipid peroxidation) and 3-NT (3-nitrotyrosine; 231 
a measure of protein tyrosine nitration) were both undetectable in epididymal adipose tissue 232 
(data not shown). No significant effect of maternal diet or CoQ supplementation was 233 
observed upon xanthine oxidase (XO) protein expression (Figure 6A). mRNA levels of 234 
components of NADPH oxidase-2 (NOX-2) (Gp91phox and P22phox) were unchanged by 235 
maternal diet; however, CoQ supplementation reduced Gp91phox (p<0.001) and P22phox 236 
(p<0.01) levels, (Figure 6B). No significant effect of maternal diet or CoQ supplementation 237 
was observed upon manganese superoxide dismutase (MnSOD) or glutathione reductase (GR) 238 
protein expression (Figure 6C). Catalase protein expression was significantly (p<0.01) 239 
increased in recuperated offspring compared to controls (Figure 6C), and this effect remained 240 
unaffected by CoQ supplementation.  241 
242 
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DISCUSSION: 243 
Previous studies by us and others have demonstrated that adipose tissue is very 244 
vulnerable to the effects of developmental programming and is the site wher some of the 245 
earliest and most striking programming effects are observed (15, 30, 31). Consistent with 246 
these observations, in the current study, we have shown a reduction in IRS-1 and p110-β 247 
insulin signaling protein expression in response to suboptimal nutrition in utero and catch-up 248 
growth. In contrast, maternal diet increased protein expression of PKC-ζ in adipose tissue and 249 
liver, which can negatively regulate insulin signaling via serine phosphorylation of IRS-1 250 
(32). All of these differences are therefore consistent with an insulin resistant phenotype. 251 
These alterations are present in adipose tissue prior to any such defects in liver or skeletal 252 
muscle. The differences in adipose tissue insulin signaling proteins are present at a time when 253 
animals display no difference in fasting glycaemia or insulinaemia. These defects are 254 
therefore not a consequence of metabolic dysfunction and more likely a contributor to the 255 
increased risk of insulin resistance in the recuperated offspring (33).   256 
The changes in p110β and IRS-1 protein expression were not accompanied by altered 257 
mRNA expression, which suggests the involvement of posttranscriptional regulatory 258 
mechanisms. However, none of the seven candidate miRNAs predicted to regulate translation 259 
of IRS-1 and/or p110β were differentially expressed in offspring epididymal adipose tissue in 260 
response to maternal diet. These could mean that a simple concentration change of 261 
complementary miRNAs is not the cause of altered protein expression of IRS-1 and p110-β, 262 
or that other undefined miRs or other posttranscriptional mechanisms are involved.  263 
A clinically relevant dietary supplementation of CoQ normalized the defects in 264 
adipose tissue insulin signaling protein expression in recuperated offspring. In addition, CoQ 265 
supplementation increased p110β protein expression in liver and skeletal muscle. This is 266 
consistent with previous studies showing that administration of a much higher dose of CoQ 267 
(20 mg/kg) affects insulin sensitivity and has anti-diabetic properties via increasing the 268 
activity of phosphatidylinositol kinase (PI3K) in the liver and skeletal muscle of rats fed a 269 
high-fat, high-fructose diet (34). It is unclear how CoQ supplementation has its effects on 270 
13 
insulin signaling protein expression. However, uptake of CoQ into most tissues is thought to 271 
be low (35) and a systemic effect is likely to be involved. 272 
Inflammation is an important factor in the development of insulin resistance via 273 
inhibition of insulin signaling through activation of IKK-β and JNK pathways (36). IL-6, IL-274 
1β, tumor necrosis factor-α (TNF-α), monochemoattractant protein-1 (MCP-1), transforming 275 
factor-β1 (TGF-β1) and leptin are major cytokines and chemokines that can be secreted by 276 
dysfunctional adipocytes or infiltrated adipose tissue macrophages. These factors play a 277 
pivotal role in adipose tissue-induced low-grade systemic inflammation and/or obesity. In the 278 
current study, we demonstrated increased protein expression of IL-6 and IL-1β in the 279 
epididymal fat pads of recuperated offspring. IL-6 is known to inhibit protein and mRNA 280 
expression of IRS-1 (37), suggesting that the increased IL-6 levels could, at least in part, 281 
explain the observed reduction in IRS-1 protein levels in recuperated animals. Furthermore, 282 
IL-1β is a key factor in mediating macrophage-induced insulin resistance in human adipocytes 283 
(38). However Mcp-1 expression (a key chemokine that regulates migration and infiltration of 284 
monocytes and macrophages) was unaltered between groups, suggesting that any macrophage 285 
infiltration in recuperated adipose tissue could be via an Mcp-1 independent mechanism. 286 
Interestingly, this pro-inflammatory phenotype occurred in the absence of obesity, suggesting 287 
that maternal suboptimal nutrition is the driving factor for this effect in a manner that is 288 
independent of offspring adiposity. CoQ supplementation significantly reduced IL-6 protein 289 
and Tgf-β1 and Lep mRNA levels, which is in agreement with findings in cardiac tissue (25), 290 
and CoQ is known to have anti-inflammatory properties in mouse liver (39) and human 291 
plasma (40) however, to our knowledge this is the first time that CoQ has been demonstrated 292 
to have anti-inflammatory properties in adipose tissue. This highlights the function of CoQ as 293 
an important anti-inflammatory molecule and may partially explain some of our reported 294 
‘insulin sensitizing’ effects of CoQ.  295 
Over-production of reactive oxygen species (ROS) is well-known to contribute to the 296 
development of insulin resistance. In the current study, however, no evidence of an oxidative 297 
stress phenotype was observed in the adipose tissue of recuperated animals, given that 298 
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Gp91phox, P22phox and xanthine oxidase (all important sources of ROS) were unaltered by 299 
maternal diet and indicators of oxidative stress such as 4-HNE and 3-NT were undetectable. 300 
This suggests that the manifestation of insulin resistance in recuperated offspring may be 301 
driven by inflammation and not oxidative stress at this age. Previously, we have described an 302 
oxidative stress phenotype in other tissues from recuperated offspring adipose tissue at 3 303 
months of age, including pancreatic islets (41) and the heart (23), and its absence in the 304 
adipose tissue highlights the tissue-specificity of developmental programming on the 305 
manifestation of oxidative stress. mRNA levels of Gp91phox and P22phox were significantly 306 
decreased by CoQ supplementation, demonstrating that CoQ has a role as a potent antioxidant 307 
in adipose tissue.  308 
In conclusion, a suboptimal maternal environment and rapid postnatal catch-up growth 309 
initiates dysregulation of insulin signaling protein expression in epididymal adipose tissue 310 
that may contribute to later development of whole body insulin resistance. This was 311 
associated with increased expression of inflammatory markers, independent of increased ROS  312 
generation and independent of obesity. CoQ supplementation ameliorated both insulin 313 
signaling dysfunction and inflammation in the adipose tissue of ‘recuperated’ offspring, 314 
suggesting that CoQ’s anti-inflammatory actions may play some role in modulating insulin 315 
resistance. Although the mechanism through which CoQ mediates these changes in adipose  316 
tissue is currently unknown, it is plausible that CoQ could act via antioxidant mechanisms to  317 
impact on the activity of genes involved in regulation of transcription or translation.318 
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FIGURE LEGENDS: 319 
Figure 1 - The effect of in utero protein restriction, accelerated postnatal growth and CoQ 320 
supplementation upon plasma CoQ levels in 3-month-old male rats. Results are expressed as 321 
mean  S.E.M. * p<0.01 (C and R versus CQ and RQ). C = control; CQ = control CoQ; R = 322 
recuperated; RQ = recuperated CoQ. N = 10 per group. 323 
Figure 2 - The effect of in utero protein restriction, accelerated postnatal growth and CoQ 324 
supplementation upon protein expression of insulin signaling molecules in A) epididymal 325 
adipose tissue, B) liver and C) VL skeletal muscle in 3-month-old male rats. Results are 326 
expressed as mean  S.E.M. * p<0.01 and *** p<0.001 (C versus R) and * p<0.01 and *** 327 
p<0.001 (R vs RQ). C = control; CQ = control CoQ; R = recuperated and RQ = recuperated 328 
CoQ.  N = 5 - 6 per group. 329 
Figure 3 - The effect of in utero protein restriction and accelerated postnatal growth upon 330 
gene expression of insulin signaling molecules in A) epididymal adipose tissue, B) liver and 331 
C) VL skeletal muscle in 3-month-old male rats. Results are expressed as mean  S.E.M. N = 332 
8 per group. 333 
Figure 4 - The effect of in utero protein restriction and accelerated postnatal growth upon 334 
miRNA targets to A) p110β and B) IRS-1. Results are expressed as mean  S.E.M. N = 10 per 335 
group. 336 
Figure 5 - The effect of in utero protein restriction, accelerated postnatal growth and CoQ 337 
supplementation upon cytokine protein and gene expression in epididymal adipose tissue in 3-338 
month-male rats. Results are expressed as mean  S.E.M. * p<0.05 (C versus R) and * p<0.05 339 
(R vs RQ). C = control; CQ = control CoQ; R = recuperated and RQ = recuperated CoQ. N = 340 
5 - 6 per group. 341 
Figure 6 - The effect of in utero protein restriction, accelerated postnatal growth and CoQ 342 
supplementation upon A) and B) sources of ROS and C) antioxidant defense capacity in 3-343 
month-old male rat epididymal adipose tissue. Results are expressed as mean  S.E.M. * 344 
16 
p<0.05 (C and R versus CQ and RQ). C = control; CQ = control CoQ; R = recuperated and 345 
RQ = recuperated CoQ. N = 6 per group.  346 
 347 
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Table 1  
Primer Sequence (F) Sequence (R) 
Irs-1 TGGCAGTGAGGATGTGAAAC CTTGGATGC TCCCCC TAGAT 
p110-β TGAGGTTGTGAGCACCTCTG CTTTGTTGAAGGCTGCTGTG 
Pkc-ζ GGGTGGATGGGATCAAAATC GGAGGACCTTGGCATAGCTT 
Tnf-α CCTCCTCTCTGCCATCAAGA TGGAAGACTCCTCCCAGGTA 
Tgfβ1 TGCCCTCTACAACCAACACA CTTGCGACCCACGTAGTAGA 
Leptin AAGCCTCGCTCTACTCCACA CATTCAGGGCTAAGGTCCAA 
Mcp1 TGGACCAGAACCAAGTGAGA TGCTGAAGTCCTTAGGGTTGA 
Gp91phox CGAAGCCTTGGCTAAAACTCT TCCTTGTTGAAGATGAAGTGGA 
P22phox GTGAGCAGTGGACTCCCATT GTAGGTGGCTGCTTGATGGT 
P47phox TGTGACACCCTCTCACAGACA GTCGCATTTTCCCTCCTTTA 
Table 2: Effect of poor maternal nutrition and accelerated postnatal growth on body and organ weights 
in 3 month male rats. 
 
Group Body weight (g) Epididymal fat pad 
weight (g) 
 
Liver weight 
(g) 
Control  483 ± 12 
 
8.0 ± 0.5 17.0 ± 0.6 
Recuperated 478 ± 8.8 
 
9.0 ± 0.6 * 17.2 ± 0.4 
Control CoQ  476 ± 12.3 
 
8.2 ± 0.5 16.7 ± 0.6 
Recuperated CoQ  482 ± 6.0 
 
9.6 ± 0.5 * 18.0 ± 0.6 
 
* p<0.05 (overall effect of maternal diet) 
 
 
 
 
 
 
Table 3: Effect of poor maternal nutrition and accelerated postnatal growth on blood glucose, insulin 
and lipid profile in 3 month male rats. 
 
Group FPG 
(mmol/L) 
Fasting serum 
insulin (mmol/L) 
Total cholesterol 
(mmol/L) 
FFAs 
(mmol/L) 
Triglycerides 
(mmol/L) 
Control (g)  
5.6 ± 0.2 
 
95 ± 26 
 
2.3 ± 0.1 
 
1052 ± 99 
 
1.7 ± 0.3 
Recuperated (g)  
5.5 ± 0.2 
 
49 ± 13 
 
2.0 ± 0.1 
 
990 ± 60 
 
1.6 ± 0.1 
Control CoQ (g)  
5.4 ± 0.1 
 
47 ± 13 
 
2.1 ± 0.1 
 
1051 ± 94 
 
1.8 ± 0.2 
Recuperated 
CoQ (g) 
 
5.4 ± 0.1 
 
47 ± 18 
 
2.1 ± 0.2 
 
976 ± 44 
 
2.0 ± 0.4 
 
 
Table 4: Effect of poor maternal nutrition and accelerated postnatal growth on insulin signaling 
molecule protein expression in 3 month male rats. 
 
  
Epididymal 
 
Fat 
 
Liver  
  
Vastus  
 
lateralis 
  
Control   
 
Recup 
 
 
Control  
 
Recup  
 
 
Control 
 
Recup  
 
IR-β 
 
100 ± 6 
 
97 ± 9 100 ± 17 139 ± 17 100 ± 7 119 ± 10  
p85-α 
 
100 ± 7 
 
101 ± 6 
 
100 ± 11 111 ± 8 100 ± 7 112 ± 4 
pAkt (ser473) 100 ± 20 
 
130 ± 25 
 
100 ± 10 110 ± 9 100 ± 17 141 ± 21 
GLUT-4 
 
100 ± 25 
 
146 ± 21 - 
 
- 
 
100 ± 17 107.7 ± 21
Akt-1 100 ± 3 96 ± 3 100 ± 8 103 ± 6 100 ± 8 85 ± 11 
Akt-2 100 ± 5 96 ± 3 100 ± 4 115 ± 7 100 ± 6 107 ± 6 
  






